Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6114089 | Transfusion and Apheresis Science | 2014 | 6 Pages |
Abstract
We reviewed retrospectively 317 patients who received 2730 plasma exchange (PE) procedures. According to guidelines published by the American Society for Apheresis (ASFA) in 2013, there were 220 (69%), 55 (17%), 32 (9%), and 7 (4%) patients who were treated with PE for a disease or condition considered as category I, II, III, and IV, respectively. Overall, 73%, 72%, and 69% of the patients showed an improvement of the underlying disease or condition at the end of the PE, and at 3 months and at 6 months after finishing the PE, respectively. We observed adverse effects in 90 (3%) PEs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Joan Cid, Gloria Carbassé, Bienvenida Andreu, Antonio Baltanás, Ana Garcia-Carulla, Miguel Lozano,